NCT05300412View on ClinicalTrials.gov

The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer

CompletedOBSERVATIONAL
Enrollment

275

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

September 10, 2019

Study Completion Date

December 20, 2019

Conditions
Breast Cancer Invasive
Trial Locations (1)

10000

Faton I. Sermaxhaj, MD, Pristina

All Listed Sponsors
lead

University Clinical Centre of Kosova

OTHER

NCT05300412 - The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer | Biotech Hunter | Biotech Hunter